Late Phase Clinical Trials – from Phase IIb to post-marketing observation

Choose Datapharm Australia for

  • Proven experience and reliability in all aspects of late phase clinical trials both local initiated and as partner for global CROs
  • Strong working relationship with large number of local investigational sites including therapeutic networks allowing selection of ideal sites for your study
  • Understanding and medical experience in a wide range of therapeutic areas
  • Developed recruitment strategies including use of social media to meet enrolment targets
  • EDC system which allows global real-time monitoring of patient status
  • Statistical expertise in trial design and results analyses

Late phase clinical trials can assess

  • Efficacy
  • Safety
  • Post-marketing use and prescribing practice

Late phase Clinical Trials – Experience

Datapharm Australia has over 25 years of experience in conducting clinical trials during all phases of product development. Datapharm has experience selecting and working with sites throughout Australia and New Zealand and through the DAI-SYS group is able to provide complete global CRO oversight of your late phase clinical trials. Datapharm is proud to have been involved in over 70 late phase clinical trials. Several of these were pivotal Phase III trials leading to regulatory approval and marketing. Our experienced teams of clinical trials specialists can design, manage and conduct all aspects of your late phase trial to local and international standards.